Myriad Genetics Inc

MYGN

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000899923

SEC filings (opens in a new tab)

No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Myriad Genetics Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of MYGN: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	201	2	213	+14
Shares	75.5M	207.6K	79.3M	+4.00M (+5.3%)
Value	$2.31B	$6.35M	$2.56B	+$258.4M (+11.2%)

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Myriad Genetics Inc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to MYGN in Q3 2021
Institution	Shares	Value	% of portfolio
Polar Asset Management Partners Inc.	591,000	$19.1M	0.23%
CastleArk Alternatives, LLC	292,850	$9.46M	0.36%
Balyasny Asset Management LLC	221,193	$7.14M	0.03%
Pictet Asset Management SA	201,376	$6.50M	0.01%
Allianz Asset Management GmbH	131,452	$4.25M	0.00%
Engineers Gate Manager LP	48,153	$1.55M	0.09%
Jackson Creek Investment Advisors LLC	32,917	$1.06M	0.39%
Twinbeech Capital LP	32,598	$1.05M	0.07%
Maryland State Retirement & Pension System	30,571	$1.01M	0.03%
Ci Investments Inc.	21,280	$687.0K	0.00%
Baird Financial Group, Inc.	14,341	$463.0K	0.00%
Redhawk Wealth Advisors, Inc.	11,955	$386.0K	0.11%
Advisors Preferred, LLC	11,259	$359.0K	0.05%
Allstate Corp	10,965	$354.0K	0.01%
Janus Henderson Group PLC	7,591	$245.0K	0.00%
Walleye Capital LLC	7,381	$238.0K	0.01%
Cresset Asset Management, LLC	7,081	$228.0K	0.00%
Burney Co	6,735	$217.0K	0.01%
Eudaimonia Partners, LLC	6,732	$217.0K	0.04%
Acadian Asset Management LLC	2,713	$85.0K	0.00%
Banque Cantonale Vaudoise	2,012	$65.0K	0.00%
PSI Advisors, LLC	250	$8.00K	0.00%
Country Trust Bank	151	$5.00K	0.00%
Quadrant Capital Group LLC	93	$3.00K	0.00%
Jones Financial Companies LLLP	60	$2.00K	0.00%
First Horizon Advisors, Inc.	27	$0	0.00%
Prestige Wealth Management Group LLC	12	$0	0.00%

Sold out (13)

Institutions that held Myriad Genetics Inc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of MYGN in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Voloridge Investment Management, LLC	149,831	$4.58M
Amundi	136,000	$4.16M
Two Sigma Investments, LP	86,256	$2.64M
SummerHaven Investment Management, LLC	36,725	$1.12M
Jane Street Group, LLC	21,200	$648.0K
Assenagon Asset Management S.A.	18,036	$552.0K
HSBC Holdings PLC	15,023	$454.0K
Eqis Capital Management, Inc.	12,676	$388.0K
Old Mission Capital LLC	10,463	$320.0K
Vident Investment Advisory, LLC	6,689	$205.0K
Parisi Gray Wealth Management	4,340	$133.0K
Lazard Asset Management LLC	1,774	$54.0K
FORA Capital, LLC	1,027	$31.0K

Not filed for Q3 2021 yet (2)

Institutions that held Myriad Genetics Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MYGN in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Pictet Asset Management Ltd	204,267	$6.25M
CWM, LLC	3,375	$103.0K